Image

Advance Care Planning in the Emergency Department

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

This is a two-armed, parallel-design, pre-/post-intervention assessment study. The investigators will conduct a randomized controlled trial for ED GOAL on a cohort of 120 older adults with serious illness to collect patient-centered outcomes and determine preliminary efficacy on increasing advance care planning engagement (self-reported and/or in the electronic medical record) one month after leaving the emergency department. The investigators will also conduct qualitative interviews with participants of ED GOAL.

Description

ED GOAL, a 6-minute motivational interview conducted in the emergency department (ED), which engages participants to address advance care planning (ACP) conversations with their outpatient clinicians and avoids a time-consuming, sensitive conversation in the time-pressured ED environment. This study is designed to determine the preliminary efficacy of ED GOAL on increasing ACP engagement (by self-report and in the electronic medical record) one month after leaving the ED.

Eligibility

Inclusion Criteria:

  1. ≥50 years of age AND ≥1 Serious illness* OR ED clinician would not be surprised if patient died in the next 12 months (a validated prognostic sign)
  2. English-speaking
  3. Capacity to consent
    1. Patient with mild cognitive impairment or mild dementia with capacity to consent (requires a caregiver/study partner to enroll)
    2. Caregiver of patient with moderate/severe dementia with capacity to consent
        (*) NYHA Stage III/IV congestive heart failure, chronic obstructive lung disease on home
        oxygen, chronic kidney disease on dialysis, or metastatic solid tumor cancer. In addition,
        patients with NYHA Stage I/II congestive heart failure, chronic obstructive lung disease
        not on home oxygen, chronic kidney disease not on dialysis will be included if recent
        hospitalization in the last 12 months exists.
        Exclusion Criteria:
          1. Acute physical or emotional distress
          2. Determined by treating or study clinician not to be appropriate
          3. Clearly documented goals for medical care** (Unless the treating or study clinician
             recommends that the intervention is clinically indicated)
          4. Delirium (assessed using 3D-CAM)
          5. Already enrolled in this study
          6. Unable/unwilling to schedule the follow-ups on the calendar
          7. Receive both the outpatient care for serious illness and primary care outside of the
             Mass General Brigham health system
        (**)e.g., MOLST, medical order for life-sustaining treatment, documented serious illness
        conversations in clinician notes within the last 3 months, etc.

Study details

Congestive Heart Failure, Metastatic Cancer, Chronic Kidney Disease Requiring Chronic Dialysis, Chronic Obstructive Pulmonary Disease

NCT05209880

Brigham and Women's Hospital

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.